Antrodia cinnamomea

Antrodia cinnamomea contains over 200 bioactive compounds — prominently lanostane-type triterpenoids (antcins A–K, eburicoic acid, dehydrosulfurenic acid) and structurally complex polysaccharides (ACP, ACP2, ACPS-1) — that exert hepatoprotective, immunomodulatory, and anticancer effects through glucocorticoid-like receptor mimicry, NF-κB/Nrf2 pathway modulation, and macrophage activation. Preclinical data show antcin K reaches concentrations of 15.25 mg/g in disc-cultured fruiting bodies and total triterpenoids in the red phenotype reach 116.4 mg/g, with demonstrated cytotoxicity against multiple human cancer cell lines and a NOAEL of 1000 mg/kg/day established in 90-day rat toxicity studies.

Origin & History

Antrodia cinnamomea is a rare, endemic bracket fungus native exclusively to Taiwan, where it parasitizes the inner heartwood of the ancient endemic tree Cinnamomum kanehirae (Taiwan sassafras). Wild fruiting bodies develop slowly on decaying logs in old-growth mountain forests, historically making collection extremely limited and the material highly prized. Due to near-depletion of wild host trees from logging, commercial cultivation via solid-state fermentation, submerged mycelial fermentation, and disc (plate) culture methods has been developed to produce standardized material for research and supplementation.

Historical & Cultural Context

Antrodia cinnamomea — called 'Niu-Chang-Chih' (牛樟芝) in Mandarin, meaning 'camphor mushroom' — has been used for centuries by indigenous Taiwanese peoples, particularly the Atayal and other highland tribes, as a folk remedy for liver ailments, food and alcohol poisoning, abdominal pain, hypertension, itchy skin, and tumor-like growths. Its extreme rarity on the wild host tree Cinnamomum kanehirae, combined with the slow growth of fruiting bodies (often taking years to form), gave it an almost mythological status in Taiwanese herbalism and commanded prices historically exceeding those of ginseng or Ganoderma lucidum. Traditional preparation involved drying wild fruiting bodies and consuming them as a tea decoction or steeping them in strong spirits to extract fat-soluble bioactives, a method that likely enriches triterpenoid content. Government-level conservation of C. kanehirae in Taiwan and commercial cultivation development from the 1990s onward transformed Antrodia cinnamomea from an exclusively wild luxury material into a mainstream Taiwanese nutraceutical industry product worth hundreds of millions of New Taiwan dollars annually.

Health Benefits

- **Hepatoprotection**: The polysaccharide ACP2, containing a distinctive 6-deoxyglucose chain, reduces lipopolysaccharide-induced hepatocyte inflammation, while multiple triterpenoids collectively attenuate oxidative hepatic injury, supporting the fungus's primary traditional use as a liver-protective agent.
- **Anticancer Activity**: ACPS-1 polysaccharide and the ubiquinone derivative 4-acetylantroquinonol B (MW 462.6 g/mol) demonstrate antiproliferative activity against mouse and human cancer cell lines in vitro, with triterpenoids inducing apoptosis through disruption of mitochondrial membrane potential and cell cycle arrest.
- **Immunomodulation**: ACP polysaccharide stimulates phagocytosis and bactericidal activity in J774A.1 macrophages by activating protein kinase C-α and triggering mitogen-activated protein kinase phosphorylation cascades, enhancing innate immune surveillance.
- **Anti-Inflammatory Effects**: Antcin A mimics glucocorticoid action via its C-7 carbonyl/hydroxyl structural motif, suppressing pro-inflammatory cytokine production, while antrolone balances NF-κB inhibition with Nrf2 pathway activation to reduce LPS-induced inflammation in RAW264.7 macrophage cells.
- **Antidiabetic Potential**: Triterpenoids including eburicoic acid, sulfurenic acid, and dehydrosulphurenic acid exhibit antidiabetic activity in preclinical models, likely through inhibition of α-glucosidase and modulation of insulin-signaling pathways, though human data are absent.
- **Neuroprotection**: Ubiquinone derivatives isolated from Antrodia cinnamomea protect PC12 neuronal cells against 6-hydroxydopamine-induced neurotoxicity, a standard model of dopaminergic cell death relevant to Parkinson's disease pathology.
- **Antioxidant Activity**: The red phenotype (RAC), with total triterpenoids of 116.4 mg/g versus 63.9 mg/g (yellow) and 51.3 mg/g (white), demonstrates the strongest free-radical scavenging capacity, with ergosterol peroxide and other sterol derivatives contributing to overall antioxidant defense.

How It Works

The polysaccharide ACP activates macrophage innate immunity through protein kinase C-α phosphorylation and downstream mitogen-activated protein kinase (MAPK) signaling, enhancing phagocytic and bactericidal function; the structurally distinct ACP2 suppresses hepatic inflammation by attenuating LPS-triggered TLR4/NF-κB signaling, an effect attributed to its 6-deoxyglucose side chain reducing receptor affinity. Antcin A and related lanostane triterpenoids structurally resemble glucocorticoids and interact with glucocorticoid response elements via a C-7 carbonyl/hydroxyl configuration, suppressing COX-2, iNOS, TNF-α, and IL-6 transcription, while antrolone dually inhibits NF-κB nuclear translocation and upregulates Nrf2-driven antioxidant gene expression (HO-1, NQO1) to resolve oxidative-inflammatory stress. At the anticancer level, triterpenoids and 4-acetylantroquinonol B induce intrinsic apoptosis by collapsing mitochondrial membrane potential, activating caspase-3/9, and modulating Bcl-2/Bax ratios, while also arresting cells in G0/G1 or G2/M phases through cyclin-CDK complex inhibition. Neuroprotective ubiquinone derivatives act as mitochondrial electron-transport-chain cofactors and free-radical scavengers, counteracting 6-hydroxydopamine-induced ROS accumulation and restoring mitochondrial membrane integrity in dopaminergic PC12 cells.

Scientific Research

The research base for Antrodia cinnamomea consists almost entirely of in vitro cell-culture experiments and rodent in vivo studies; no peer-reviewed, randomized controlled clinical trials in human populations with defined sample sizes and effect sizes have been published as of the latest search results. Preclinical anticancer work has examined ACPS-1 polysaccharide and triterpenoid fractions against established mouse (S180, H22) and human (HepG2, MCF-7, A549) cell lines, reporting IC50 values in the low-to-mid micromolar range, but these findings cannot be directly translated to human efficacy without pharmacokinetic bridging studies. A 90-day subchronic oral toxicology study in Sprague-Dawley rats at doses up to 1000 mg/kg/day established a NOAEL with no observed changes in mortality, body weight, organ weights, hematology, serum biochemistry, or histopathology, providing a formal safety anchor. The phenotypic comparison of red, yellow, and white Antrodia cinnamomea demonstrated that the red (RAC) phenotype contains the highest triterpenoid content (116.4 mg/g) and greatest bioactivity in screening assays, informing cultivation standardization, but the overall evidence remains at the preclinical stage and should be interpreted with caution.

Clinical Summary

No peer-reviewed human clinical trials with quantified primary endpoints, randomized allocation, or reported confidence intervals have been identified for Antrodia cinnamomea in the available literature. The most structured human-relevant data derive from a rodent subchronic toxicity study establishing a NOAEL of 1000 mg/kg/day, from which a provisional human equivalent dose of approximately 50 mg/kg/day is extrapolated using standard allometric scaling. Anticancer, hepatoprotective, and immunomodulatory claims rest entirely on in vitro and animal model data, which, while mechanistically coherent and internally consistent, cannot substitute for controlled human trials. Confidence in therapeutic efficacy for any specific clinical indication in humans must therefore be rated as very low pending adequately powered Phase I/II trials.

Nutritional Profile

Antrodia cinnamomea is not consumed as a dietary staple and does not contribute meaningfully to macronutrient intake at supplemental doses; its nutritional significance lies entirely in its dense concentration of specialized secondary metabolites. Total crude polysaccharides constitute up to 40.96% of dry-weight extract, dominated by mannose-rich heteropolysaccharides (ACP: 75% mannose, 25% galactose; ACP2: glucose:galactose:6-deoxyglucose at 5:2:1; ACPS-1: mannose:xylose:arabinose:fucose:rhamnose at 31.27:1.77:1.44:1.34:1.00). Total triterpenoids range from 51.3 mg/g (white phenotype) to 116.4 mg/g (red phenotype), with disc-cultured fruiting bodies yielding antcin C at 10.25 mg/g, antcin K at 15.25 mg/g, antcin B at 3.94 mg/g, dehydrosulfurenic acid at 5.10 mg/g, and dehydroeburicoic acid at 2.41 mg/g as benchmark reference compounds. Ubiquinone (coenzyme Q) derivatives, ergosterol, ergosterol peroxide, and maleic/succinic acid derivatives contribute additional bioactivity; formal macro- and micronutrient panels and oral bioavailability data for individual compounds in humans have not been published.

Preparation & Dosage

- **Fruiting Body Powder (disc/plate-cultured)**: The most triterpenoid-rich form; provisionally used at ~50 mg/kg body weight per day (human equivalent extrapolated from rat studies); standardize to total triterpenoid content, preferably red phenotype (RAC) at ≥100 mg/g total triterpenoids.
- **Mycelial Extract (solid-state or submerged fermentation)**: Commonly encapsulated at 200–500 mg per dose; submerged fermentation yields consistent polysaccharide profiles; verify ACP/ACPS-1 polysaccharide content on certificate of analysis.
- **Ethanol Extract (standardized)**: Prepared via sequential ethanol extraction followed by silica-gel column chromatography or HPLC purification; used in most preclinical triterpenoid studies; typical research concentrations 50–200 µg/mL in vitro; human oral equivalent not yet clinically validated.
- **Traditional Decoction**: Historically, slices of wild fruiting body were simmered in water or soaked in Taiwanese rice wine (mijiu); no standardized preparation protocol exists; bioavailability from this form is undocumented.
- **Timing and Administration**: Preclinical oral dosing administered with food to minimize gastric irritation; no clinical data define optimal timing, but fat co-ingestion is theoretically favorable for lipophilic triterpenoid absorption.
- **Standardization Note**: Look for products standardized to antcin C (≥10 mg/g) or antcin K (≥15 mg/g) as reference markers, consistent with disc-cultured fruiting body benchmarks reported in published analytical studies.

Synergy & Pairings

Antrodia cinnamomea triterpenoids are lipophilic and are theoretically enhanced in absorption when co-administered with phospholipid-based delivery systems (e.g., lecithin) or omega-3-rich oils; pairing with silymarin (milk thistle) may provide complementary hepatoprotective mechanisms — Antrodia acting via polysaccharide-driven anti-inflammatory pathways and silymarin via flavonolignan-mediated hepatocyte membrane stabilization and CYP2E1 inhibition. Combination with Ganoderma lucidum (reishi) polysaccharides is a traditional Taiwanese practice, and both share TLR-mediated macrophage activation pathways, suggesting additive or synergistic immunomodulatory effects at lower individual doses. Co-administration with coenzyme Q10 may amplify the mitochondrial-protective and neuroprotective effects of Antrodia's endogenous ubiquinone derivatives, particularly in oxidative-stress-related indications, though no formal combination studies have been conducted.

Safety & Interactions

A formal 90-day subchronic oral toxicology study in Sprague-Dawley rats at doses up to 1000 mg/kg/day found no mortality, no significant alterations in body weight, organ weight, food consumption, hematological indices, serum biochemistry, or histopathological findings, establishing a NOAEL of 1000 mg/kg/day — approximately 20-fold above the provisionally estimated human equivalent dose of 50 mg/kg/day. No human adverse event data, drug interaction studies, or pharmacovigilance reports are available in the published literature, meaning that interactions with hepatically metabolized drugs (CYP450 substrates), immunosuppressants, anticoagulants, or antidiabetic medications cannot be formally excluded given the fungus's broad metabolic activities. Individuals with autoimmune conditions should use caution given demonstrated macrophage and immune-stimulatory effects, and pregnant or lactating women should avoid use entirely due to the complete absence of reproductive safety data. Adulteration with non-authenticated Antrodia species or mycelium-on-grain products is a known commercial quality issue in Taiwan's supplement market, and consumers should verify species authentication via DNA barcoding or HPLC triterpenoid fingerprinting on the product certificate of analysis.